#CancerNews
LightNews LightNews
cancerresearchuk.org
Last weekend, the world's cancer scientists gathered in Madrid to share some of their latest findings at the European Society for Medical Oncology (ESMO) annual conference.

Find out more and get the reactions from our experts: cruk.ink/4zTbcD0 #CancerNews
Microscope image of purple cells with black text which reads, "What did Europe's top cancer conference tell us about the future of cancer treatment?"
October 30, 2026 at 1:04 PM
humolyte.bsky.social
Keytruda gets full FDA approval for TMB-high cancers — but the cutoff just moved from 10 to 13 www.humolyte.com/blog/keytrud... #Keytruda #Immunotherapy #CancerNews
October 26, 2026 at 11:17 PM
humolyte.bsky.social
FDA grants accelerated approval to Jemperli for rectal cancer — immunotherapy alone, no chemo, radiation, or surgery for responders www.humolyte.com/blog/jemperl... #RectalCancer #Immunotherapy #CancerNews
October 22, 2026 at 9:43 PM
humolyte.bsky.social
New FDA approval for stage III colon cancer www.humolyte.com/blog/fda-app... #ColonCancer #Immunotherapy #CancerNews
October 19, 2026 at 11:41 PM
humolyte.bsky.social
Landmark Mayo Clinic study links gut bacteria to chemo side effects www.humolyte.com/blog/gut-mic... #GutMicrobiome #Chemotherapy #CancerNews
October 20, 2026 at 4:38 AM
thecancersurvivorsclub.com
September brought a remarkable wave of progress in cancer care, with 10 FDA decisions covering breast, lung, kidney, bile duct, skin and neuroendocrine cancers, plus advances in brain tumour imaging.

www.curetoday.com/view/10-canc...

#CancerResearch #CancerTreatment #CancerNews #TCSC
10 Cancer Treatment Approvals From September 2026 and What They Mean for You | CURE
September brought new options for breast, lung, kidney, bile duct, skin and neuroendocrine cancers, plus a brain tumor scan and easier lung cancer treatment.
www.curetoday.com
October 2, 2026 at 8:31 AM
thecancersurvivorsclub.com
Six cancer drug approvals in a single month. August brought new FDA-approved treatment options across pancreatic cancer, gastroesophageal cancer, melanoma, multiple myeloma and rare blood cancers.

www.curetoday.com/view/6-cance...

#CancerTreatment #CancerResearch #CancerNews #TCSC
6 Cancer Drugs FDA Approved in August 2026 and What They Mean for You | CURE
The FDA approved six cancer drugs in August 2026, including a landmark pancreatic cancer pill. Here's what each approval means for patients and side effects.
www.curetoday.com
September 3, 2026 at 7:49 AM
peppypanda.com
Good news! Advanced cancer diagnoses are back to pre-pandemic levels. 🎉 #CancerNews #GoodNews #Healthcare
Advanced cancers returned to prepandemic levels, according to a reassuring report
"Cancer death rates continue to decline, and there weren’t huge shifts in late diagnoses, according to a new report published Monday in the journal Cancer. It’s the broadest-yet analysis of the pandemic’s effect on U.S. cancer data."
apnews.com
April 23, 2025 at 2:00 AM
gentlem.bsky.social
binaytara.org/cancernews/a...
(from Aug 2025)
Ivermectin doesn’t cure cancer.
Even in Florida.
What Cancer Doctors Are Saying About Ivermectin and Cancer Treatment | Cancer News
The Cancer News survey of oncology experts explains why ivermectin is not a proven cancer treatment, what trials exist in TNBC, and how doctors guide patients.
binaytara.org
October 21, 2025 at 11:54 AM
thecancersurvivorsclub.com
A US FDA advisory committee has backed RP1 for advanced melanoma, bringing another potential immunotherapy option a step closer for patients whose cancer has progressed.

www.curetoday.com/view/fda-adv...

#Melanoma #Immunotherapy #CancerNews #TCSC
FDA Advisory Committee Backs RP1 for Advanced Melanoma | CURE
The 10-3 vote came during a discussion in which the limitations of TIL therapy, the only approved option for this group of patients, were raised repeatedly.
www.curetoday.com
August 3, 2026 at 8:11 AM
thecancersurvivorsclub.com
Scientists have mapped where dormant cancer cells hide, revealing new clues that could one day stop cancers returning after treatment. A promising step towards preventing relapse.

medicalxpress.com/news/2026-01...

#CancerResearch #CancerNews #MetastaticCancer #TCSC
Dormant cancer cells can change shape to survive immune system attack
Cancer cells that have broken away from a primary tumor can lurk in the body for years in a dormant state, evading immune defenders and biding their time until conditions are ripe for establishing a n...
medicalxpress.com
August 3, 2026 at 8:08 AM
thecancersurvivorsclub.com
A potential game-changer for one of the toughest cancers. Daraxonrasib has nearly doubled survival in advanced pancreatic cancer trials and is generating huge excitement across the oncology community. pancan.org/news/first-r...

#PancreaticCancer #CancerNews #MedicalResearch #TCSC
First RAS Inhibitor Extends Survival in Previously Treated Metastatic Pancreatic Adenocarcinoma: What You Need to Know
Revolution Medicines shared Phase III clinical trial results for a pill called daraxonrasib in patients with previously treated metastatic pancreatic cancer.
pancan.org
June 17, 2026 at 10:29 AM
thecancersurvivorsclub.com
A single podcast appearance by Mel Gibson doubled ivermectin prescriptions in cancer patients; with no clinical trial evidence it works. Among patients with cancer, rates rose 2.5x. Doctors warn it could delay life-saving treatment. #TCSC #CancerCare #CancerNews
www.healthday.com/health-news/...
Ivermectin Prescriptions Doubled After Mel Gibson Cancer Cure Claim
WEDNESDAY, May 13, 2026 (HealthDay News) — Prescriptions for the anti-parasite medication ivermectin doubled after actor Mel Gibson endorsed the dewormer as an
www.healthday.com
May 14, 2026 at 8:07 AM
thecancersurvivorsclub.com
Lung cancer survivor Stephen Huff said biomarker testing “is the single most important thing that kept me alive.” Yesterday, the Tennessee governor signed a bill expanding coverage of that testing; a win Huff helped make happen. #TCSC #CancerSurvivor #CancerNews
www.wsmv.com/2026/05/08/g...
Gov. Lee signs cancer survivor-backed biomarker testing bill into law
Governor Bill Lee signed a bill into law Friday that will require insurance companies to cover biomarker testing.
www.wsmv.com
May 9, 2026 at 10:49 AM
thecancersurvivorsclub.com
Warning for cancer patients: biotin supplements taken for chemo hair loss may distort key blood test results; potentially masking recurrence or changing treatment plans. Ohio State researchers say talk to your oncologist first. #TCSC #CancerCare #CancerNews
www.sciencedaily.com/releases/202...
Doctors warn this popular vitamin may quietly disrupt cancer care
Many cancer patients turn to biotin supplements hoping to restore hair lost during treatment, but experts warn the popular vitamin may do more harm than good. While biotin is often marketed for strong...
www.sciencedaily.com
May 9, 2026 at 10:44 AM
thecancersurvivorsclub.com
Against all odds; 15-year-old Will Roberts posted a video asking for help fighting a rare bone cancer. The internet responded. He has now started experimental treatment in California. This is what community looks like. #TCSC #CancerSurvivor #CancerNews #CancerResearch
ktla.com/news/alabama...
Alabama teen with rare cancer who made viral plea to Trump for help gets experimental treatment in California
Where there’s a Will, there’s got to be a way.  Fifteen-year-old Will Roberts is an Alabama boy who was diagnosed with osteosarcoma in January 2025, he said in a video post…
ktla.com
May 8, 2026 at 7:19 AM
thecancersurvivorsclub.com
Good news for cancer patients in Northern Ireland: Keytruda’s one-minute injectable form is already being used across three health trusts; cutting treatment time by up to 90% and giving patients their time back. #TCSC #CancerNews #Immunotherapy #CancerResearch
www.irishnews.com/news/norther...
Revolutionary cancer drug already available in Northern Ireland
After confusion about whether Northern Ireland cancer patients were being left behind, Health Minister Mike Nesbitt confirmed Keytruda is already being used in three health trusts
www.irishnews.com
May 6, 2026 at 8:30 AM
thecancersurvivorsclub.com
Game-changer for cancer patients in England: a new subcutaneous pembrolizumab injection cuts treatment time from up to 2 hours down to just 60 seconds. 14 cancer types. 14,000 patients per year set to benefit. #TCSC #CancerNews #Oncology #NHS

www.england.nhs.uk/2026/05/1-mi...
NHS England » ‘1-minute’ immunotherapy jab rolled out on NHS for tens of thousands with cancer
NHS England » ‘1-minute’ immunotherapy jab rolled out on NHS for tens of thousands with cancer
www.england.nhs.uk
May 5, 2026 at 5:11 PM
thecancersurvivorsclub.com
Against all odds; every single patient in a bowel cancer immunotherapy trial remains cancer-free nearly 3 years later. A short course of pembrolizumab before surgery produced zero relapses. This is what hope looks like. #TCSC #Cancer #CancerNews #Immunotherapy
www.foxnews.com/health/patie...
Patients remain cancer-free nearly 3 years after receiving experimental immunotherapy
Every participant in a new bowel cancer immunotherapy trial remained cancer-free nearly three years after receiving pembrolizumab before surgery.
www.foxnews.com
May 5, 2026 at 5:09 PM
thecancersurvivorsclub.com
The treatment offers longer survival for some patients and can be combined with chemo, giving hope where options had barely changed since the 1990s. #CancerNews #Oncology #TCSC
March 25, 2026 at 7:23 AM
thecancersurvivorsclub.com
The decision, based on improved progression‑free survival over AVD alone, also converts some earlier accelerated approvals to traditional ones, cementing Opdivo’s role across relapsed and frontline Hodgkin settings. #CancerNews #Hematology #TCSC
March 24, 2026 at 7:20 AM
thecancersurvivorsclub.com
In the Beamion LUNG‑1 trial, zongertinib achieved a 76% response rate in untreated HER2‑mutant NSCLC, with many patients keeping responses beyond 6–12 months and tolerability described as manageable. #NSCLC #CancerNews #TCSC
March 23, 2026 at 8:03 AM
thecancersurvivorsclub.com
The FDA has accepted and granted Priority Review to AstraZeneca and Daiichi Sankyo’s Datroway as a first-line option for adults with metastatic triple-negative breast cancer not eligible for immunotherapy! #TCSC #CancerNews #TNBC #FDA

www.astrazeneca-us.com/media/press-...
DATROWAY® (datopotamab deruxtecan-dlnk) granted Priority Review in the US as 1st-line treatment for patients with metastatic triple-negative breast cancer who are not candidates for immunotherapy
www.astrazeneca-us.com
February 4, 2026 at 12:32 PM
thecancersurvivorsclub.com
Scientists have uncovered a new way cancer cells send and receive growth signals, opening the door to more precise, effective cancer drugs that could make treatments smarter and kinder. #CancerNews #Oncology #CancerBreakthrough #ScienceMatters #TCSC www.brown.edu/news/2025-12...
New discovery in cancer signaling reveals a potential path to more effective cancer drugs
A large, multi-institution study led by a Brown University physician-scientist could have important implications for the development of new classes of cancer therapeutics.
www.brown.edu
December 10, 2025 at 11:50 AM
thecancersurvivorsclub.com
A new study suggests many men with prostate cancer may not need long-term hormone therapy. Researchers found most ADT benefits happen in the first 9–12 months. Smarter treatment, fewer side effects. #ProstateCancer #CancerResearch #TCSC #Oncology #CancerNews #ADT

newsroom.ucla.edu/releases/lon...
Study suggests many men may not need long-term hormone therapy for prostate cancer
Shorter courses of androgen deprivation therapy could reduce risks while still effectively controlling cancer.
newsroom.ucla.edu
November 27, 2025 at 11:38 AM